CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-02 | Link Matthew Chief Commercial Officer | Sale | −5,042 | $2.31 | $12K | 830,551 |
| 2025-04-02 | Bauerlein Alison Chief Financial Officer | Sale | −19,397 | $2.31 | $45K | 649,794 |
| 2025-04-01 | Badawi Paul President and CEO | Sale | −24,174 | $2.30 | $56K | 6,010,580 |
| 2025-04-01 | Badawi David Chief Technology Officer | Sale | −5,980 | $2.30 | $14K | 1,836,704 |
| 2025-03-13 | Raheja Manohar K. EVP, Research & Development | Purchase | +10,000 | $2.60 | $26K | 155,000 |
| 2025-03-12 | Raheja Manohar K. EVP, Research & Development | Purchase | +10,000 | $2.73 | $27K | 145,000 |
| 2025-03-12 | Encrantz Staffan Director | Other acquisition | +243,000 | $2.77 | $673K | 5,086,920 |
| 2025-03-11 | Bauerlein Alison Chief Financial Officer | Grant or award | +286,738 | 669,191 | ||
| 2025-03-11 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award | +139,785 | 284,876 | ||
| 2025-03-11 | Badawi Paul President and CEO | Grant or award | +358,423 | 6,034,754 | ||
| 2025-03-11 | Badawi David Chief Technology Officer | Grant or award | +98,566 | 1,842,684 | ||
| 2025-03-11 | Link Matthew Chief Commercial Officer | Grant or award | +172,043 | 835,593 | ||
| 2025-03-11 | Raheja Manohar K. EVP, Research & Development | Grant or award | +24,000 | 135,000 | ||
| 2025-03-11 | Encrantz Staffan Director | Other acquisition | +150,000 | $2.71 | $407K | 4,843,920 |
| 2025-03-10 | Encrantz Staffan Director | Other acquisition | +120,000 | $2.53 | $304K | 4,693,920 |
| 2025-01-17 | Badawi David Chief Technology Officer | Sale | −5,423 | $2.78 | $15K | 1,744,118 |
| 2025-01-17 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −6,922 | $2.78 | $19K | 145,091 |
| 2025-01-16 | Badawi Paul President and CEO | Sale | −24,819 | $2.92 | $73K | 5,676,331 |
| 2025-01-08 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −1,810 | $3.26 | $6K | 152,013 |
| 2025-01-08 | Badawi David Chief Technology Officer | Sale | −3,829 | $3.26 | $12K | 1,749,541 |
Page 6 of 7 · 126 trades